Lumida
/MTD
⌘K
Mettler-Toledo International Inc

Mettler-Toledo International Inc

MTD
$1,310.02USD-1.88%-25.07 today

MARKET CAP

26.5B

P/E (TTM)

30.1x

FWD P/E

26.3x

DAY RANGE

$1,301 – $1,340

52W RANGE

$1,023
$1,525

AI Summary

Stalk
Buy NowHigh

MTD is in a high-confidence Stage 2 advancing regime with an active Lockout Rally driving forced participation and continuation above rising EMAs and the 50 SMA. The medium-term bias is bullish, and the Lockout Rally override signals favorable immediate execution despite overbought conditions. We will buy now, participating in the continuation above the current breakout zone.

  • Q1 revenue $947M (+7% YoY) and EPS $8.91 (+9% YoY) exceed forecasts.
  • 2026 free cash flow guidance of ~$900M enables $825–875M in share repurchases.
  • Incremental tariffs cut operating margins by 190 basis points, squeezing profits.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Mettler-Toledo International, Inc. (NYSE: MTD) is a leading global supplier of precision instruments primarily serving the laboratory, industrial, and food retail sectors across various industries, including pharmaceuticals, chemicals, and food safety. With a strong emphasis on automation and digitalization, Mettler-Toledo is well-positioned to leverage the growing demand for innovative analytical solutions while navigating ongoing regulatory pressures and macroeconomic challenges impacting market conditions globally.

Bull says

  • Q1 revenue $947M (+7% YoY) and EPS $8.91 (+9% YoY) exceed forecasts.
  • 2026 free cash flow guidance of ~$900M enables $825–875M in share repurchases.
  • Local currency sales growth forecast ~4% for 2026, driven by automation and bioprocessing.
  • Analysts see ~13.8% upside to fair value of $1,328 per share.
  • High earnings yield and strong profitability factors bolster financial resilience.
  • Automation and digitalization demand across labs and industry underpin growth pipeline.

Bear says

  • Incremental tariffs cut operating margins by 190 basis points, squeezing profits.
  • Negative growth indicators point to revenue stagnation, especially in academic and chemical segments.
  • Low institutional ownership reflects weak investor confidence and potential downward pressure.
  • Geopolitical tensions and trade uncertainty risk revenue volatility and execution delays.
  • Limited pricing power amid inflation may hinder margin recovery.
  • Sensitivity to oil prices and interest rates raises vulnerability to macro shocks.

Investment themes with MTD

SPY +0.09%

NVDA · AAPL · GOOGL
GS: Strong Pricing Power +0.77%

Companies with strong ability to set prices

META · EA · PLTK

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026bullish

Transcript signals

Bull points

  • Sales in the quarter were $947 million, which represented an increase in local currency of 3%, or 1% excluding acquisitions, which contributed approximately 1.5% to growth.
  • Local currency sales increased 1% in laboratory, increased 5% in industrial, including 1% growth in core industrial and 11% growth in product inspection. Food retail grew 7% in the quarter. Excluding acquisitions in currency, Laboratory sales were flat, while industrial increased 2%, including core industrial flat and product inspection up 6%. Lastly, service revenue grew 7% and 5% excluding acquisitions.
  • Adjusted operating profit amounted to $246 million in the quarter, up 4% versus the prior year.

Bear points

  • Gross margin was 58.7% in the quarter, a decrease of 80 basis points, and was up 10 basis points excluding unfavorable foreign currency in acquisitions.
  • We estimate the gross impact of incremental tariffs reduced our operating profit by 4%. It was a 90 basis point headwind to our operating margin.
  • our guidance includes higher costs due to inflation related to the war in the Middle East.
Read full transcript analysis ›